A phase II study evaluating CAVi (cyclophosphamide, adriamycin, vincristine) potentiated or not by amphotericin B entrapped into sonicated liposomes, as salvage therapy for small cell lung cancer-Reference-Cited by-同舟云学术

A phase II study evaluating CAVi (cyclophosphamide, adriamycin, vincristine) potentiated or not by amphotericin B entrapped into sonicated liposomes, as salvage therapy for small cell lung cancer

Published:1990-10 Issue:3-4 Volume:6 Page:110-118
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Sculier J.P.,Klastersky J.,Libert P.,Ravez P.,Brohee D.,Vandermoten G.,Michel J.,Thiriaux J.,Bureau G.,Schmerber J.,Sergysels R.,Coune A.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference29 articles.

1. Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer;Bishop;J Clin Oncol,1987

2. Mechanism of multidrug resistance;Bradley;Biochim Biophys Acta,1988

3. Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma;Chiuten;Cancer Treat Rep,1986

4. Drug resistance in cancer;Curt;Cancer Treat Rep,1984

5. Cyclic alternating ‘non-cross resistant’ chemotherapy in the management of small cell anaplastic carcinoma of the lung;Elliot;Cancer Treat Rev,1984

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and outcomes of patients with small cell lung cancer - findings from a New Zealand SACT database;Asia-Pacific Journal of Oncology;2023-02-10

2. Which chemotherapy regimen might be the best for the second-line treatment of patients with small-cell lung cancer?;Oncology in Clinical Practice;2021-12-30

3. HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer;Oncogene;2013-10-28

4. Chemotherapy and Biological Agents;Lung Cancer;2013-04-03

5. New Advances in the Second-Line Treatment of Small Cell Lung Cancer;The Oncologist;2009-10-01